132 related articles for article (PubMed ID: 14498826)
1. Lysophosphatidic acid acyltransferase-beta: a novel target for induction of tumour cell apoptosis.
Bonham L; Leung DW; White T; Hollenback D; Klein P; Tulinsky J; Coon M; de Vries P; Singer JW
Expert Opin Ther Targets; 2003 Oct; 7(5):643-61. PubMed ID: 14498826
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.
Pagel JM; Laugen C; Bonham L; Hackman RC; Hockenbery DM; Bhatt R; Hollenback D; Carew H; Singer JW; Press OW
Clin Cancer Res; 2005 Jul; 11(13):4857-66. PubMed ID: 16000584
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies.
Springett GM; Bonham L; Hummer A; Linkov I; Misra D; Ma C; Pezzoni G; Di Giovine S; Singer J; Kawasaki H; Spriggs D; Soslow R; Dupont J
Cancer Res; 2005 Oct; 65(20):9415-25. PubMed ID: 16230405
[TBL] [Abstract][Full Text] [Related]
4. Effect of lysophosphatidic acid acyltransferase-beta inhibition in acute leukemia.
Douvas MG; Hogan KN; Ji Y; Hollenback D; Bonham L; Singer JW; Mitchell BS
Leuk Res; 2006 Aug; 30(8):1027-36. PubMed ID: 16488473
[TBL] [Abstract][Full Text] [Related]
5. Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib.
La Rosée P; Jia T; Demehri S; Härtel N; de Vries P; Bonham L; Hollenback D; Singer JW; Melo JV; Druker BJ; Deininger MW
Clin Cancer Res; 2006 Nov; 12(21):6540-6. PubMed ID: 17085669
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells.
Coon M; Ball A; Pound J; Ap S; Hollenback D; White T; Tulinsky J; Bonham L; Morrison DK; Finney R; Singer JW
Mol Cancer Ther; 2003 Oct; 2(10):1067-78. PubMed ID: 14578472
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid acyltransferase beta regulates mTOR signaling.
Blaskovich MA; Yendluri V; Lawrence HR; Lawrence NJ; Sebti SM; Springett GM
PLoS One; 2013; 8(10):e78632. PubMed ID: 24205284
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC
Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006
[TBL] [Abstract][Full Text] [Related]
9. The structure and functions of human lysophosphatidic acid acyltransferases.
Leung DW
Front Biosci; 2001 Aug; 6():D944-53. PubMed ID: 11487472
[TBL] [Abstract][Full Text] [Related]
10. Identifying Lysophosphatidic Acid Acyltransferase β (LPAAT-β) as the Target of a Nanomolar Angiogenesis Inhibitor from a Phenotypic Screen Using the Polypharmacology Browser PPB2.
Poirier M; Awale M; Roelli MA; Giuffredi GT; Ruddigkeit L; Evensen L; Stooss A; Calarco S; Lorens JB; Charles RP; Reymond JL
ChemMedChem; 2019 Jan; 14(2):224-236. PubMed ID: 30520265
[TBL] [Abstract][Full Text] [Related]
11. Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis.
Niesporek S; Denkert C; Weichert W; Köbel M; Noske A; Sehouli J; Singer JW; Dietel M; Hauptmann S
Br J Cancer; 2005 May; 92(9):1729-36. PubMed ID: 15841084
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway.
Tang W; Yuan J; Chen X; Gu X; Luo K; Li J; Wan B; Wang Y; Yu L
J Biochem Mol Biol; 2006 Sep; 39(5):626-35. PubMed ID: 17002884
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, SAR, and antitumor properties of diamino-C,N-diarylpyrimidine positional isomers: inhibitors of lysophosphatidic acid acyltransferase-beta.
Gong B; Hong F; Kohm C; Jenkins S; Tulinsky J; Bhatt R; De Vries P; Singer JW; Klein P
Bioorg Med Chem Lett; 2004 May; 14(9):2303-8. PubMed ID: 15081029
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells.
West J; Tompkins CK; Balantac N; Nudelman E; Meengs B; White T; Bursten S; Coleman J; Kumar A; Singer JW; Leung DW
DNA Cell Biol; 1997 Jun; 16(6):691-701. PubMed ID: 9212163
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of lysophosphatidic acid acyltransferase beta -- evidence from membrane and whole cell assays.
Hollenback D; Bonham L; Law L; Rossnagle E; Romero L; Carew H; Tompkins CK; Leung DW; Singer JW; White T
J Lipid Res; 2006 Mar; 47(3):593-604. PubMed ID: 16369050
[TBL] [Abstract][Full Text] [Related]
16. Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family.
Li D; Yu L; Wu H; Shan Y; Guo J; Dang Y; Wei Y; Zhao S
J Hum Genet; 2003; 48(8):438-442. PubMed ID: 12938015
[TBL] [Abstract][Full Text] [Related]
17. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
Das U; Kumar S; Dimmock JR; Sharma RK
Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between lysophosphatide acid acyltransferase beta and tumor - review].
Huang HB; Zhan R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):975-8. PubMed ID: 18718103
[TBL] [Abstract][Full Text] [Related]
20. Oncogene products as therapeutic targets for cancer.
Huang PS; Heimbrook DC
Curr Opin Oncol; 1997 Jan; 9(1):94-100. PubMed ID: 9090500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
